{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T08:33:08Z","timestamp":1725870788473},"reference-count":19,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T00:00:00Z","timestamp":1236643200000},"content-version":"unspecified","delay-in-days":4086,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Technol Assess Health Care"],"published-print":{"date-parts":[[1998]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Markov modeling was used to evaluate the cost-effectiveness of octreotide in treating carcinoid syndrome and VIPoma. For each condition, using octreotide was associated with doubled survival time. Octreotide was cost-effective for treating carcinoid tumor ($752 per additional year of life, two additional years on average), and cost saving for VIPoma.<\/jats:p>","DOI":"10.1017\/s0266462300011491","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T07:20:27Z","timestamp":1236669627000},"page":"514-525","source":"Crossref","is-referenced-by-count":8,"title":["The Cost-Effectiveness of Octreotide Acetate in the Treatment of Carcinoid Syndrome and Vipoma"],"prefix":"10.1017","volume":"14","author":[{"given":"Warren H.","family":"Schonfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Elkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene A.","family":"Woltering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irvin M.","family":"Modlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lowell","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen F.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Zagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"S0266462300011491_ref010","doi-asserted-by":"publisher","DOI":"10.3109\/02841869309083912"},{"key":"S0266462300011491_ref014","volume-title":"Redbook","year":"1994"},{"key":"S0266462300011491_ref012","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2"},{"key":"S0266462300011491_ref016","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9301300409"},{"key":"S0266462300011491_ref005","first-page":"583","article-title":"The cost-effectiveness of prenatal care in reducing low birth weight in New Hampshire","volume":"24","author":"Gorsky","year":"1989","journal-title":"Health Services Research"},{"key":"S0266462300011491_ref008","first-page":"33","article-title":"The carcinoid syndrome: A treatable malignant disease","volume":"2","author":"Kvols","year":"1988","journal-title":"Oncology"},{"key":"S0266462300011491_ref001","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(99)80210-4"},{"key":"S0266462300011491_ref002","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-3-214"},{"key":"S0266462300011491_ref004","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-1-35"},{"key":"S0266462300011491_ref007","volume-title":"Harrison's principles of internal medicine","author":"Kaplan","year":"1991"},{"key":"S0266462300011491_ref009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198609113151102"},{"key":"S0266462300011491_ref013","volume-title":"Physician's Fee and Coding Guide","year":"1994"},{"key":"S0266462300011491_ref015","doi-asserted-by":"publisher","DOI":"10.1126\/science.2510299"},{"key":"S0266462300011491_ref017","first-page":"24","article-title":"The role of somatostatin analogs in the treatment of endocrine gastrointestinal tumors","volume":"27","author":"Trautmann","year":"1993","journal-title":"Hormone and Metabolic Research"},{"key":"S0266462300011491_ref019","first-page":"246","article-title":"Drug therapy","volume":"334","author":"Wood","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"S0266462300011491_ref011","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-3-192"},{"key":"S0266462300011491_ref006","volume-title":"SMLTREE version 2.99 decision analysis software","author":"Hollenberg","year":"1993"},{"key":"S0266462300011491_ref018","volume-title":"Textbook of secretory diarrhea","author":"Vinik","year":"1990"},{"key":"S0266462300011491_ref003","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-5-389"}],"container-title":["International Journal of Technology Assessment in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0266462300011491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T15:33:54Z","timestamp":1557588834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0266462300011491\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998]]}},"alternative-id":["S0266462300011491"],"URL":"https:\/\/doi.org\/10.1017\/s0266462300011491","relation":{},"ISSN":["0266-4623","1471-6348"],"issn-type":[{"value":"0266-4623","type":"print"},{"value":"1471-6348","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998]]}}}